High Vista Strategies LLC Biogen Inc. Transaction History

High Vista Strategies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $692,442 - $841,332	2,743 New	2,743 $759,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $3.12 Million - $3.95 Million	-11,590 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $4.02 Million - $4.43 Million	-18,319 Reduced 61.25%	11,590 $2.71 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $260,052 - $406,752	1,200 Added 4.18%	29,909 $7.07 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1.28 Million - $1.62 Million	-4,600 Reduced 13.81%	28,709 $8.64 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $58,702 - $76,766	200 Added 0.6%	33,309 $11.8 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $25,752 - $30,691	-100 Reduced 0.3%	33,109 $9.61 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $26,013 - $36,791	100 Added 0.3%	33,209 $9.09 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $92,292 - $103,374	-300 Reduced 0.9%	33,109 $10.5 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $9.39 Million - $11 Million	33,409	33,409 $10.5 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.